Consistent with this, Achinger-Kawecka et al. found that 3D genome remodelling during the development of endocrine resistance in ER+ breast cancer cells is mediated by ERα binding66, further linking ERα with 3D genome organization. The gene discussed is ESR1; the disease is breast cancer.